作为KRAS突变结肠直肠癌的潜在治疗点的核糖体生物发生
Yui Tanaka1,2, Mizuho Sakahara1, Hitomi Yamanaka1
1Department of Cell Biology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Nature communications
|December 27, 2025
概括
针对KRAS的疗法可以导致结直肠癌细胞促进核糖体的产生,使它们易受RNA聚合酶I抑制的影响. 这一发现为KRAS突变结直肠癌提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 在结直肠癌 (CRC) 的发展中,KRAS信号通路至关重要.
- 目前针对KRAS的治疗方法在CRC中有效性有限.
- 在KRAS突变CRC中药物耐药性机制需要进一步研究.
研究的目的:
- 在结直肠癌中研究细胞对KRAS信号抑制的反应.
- 确定克服KRAS突变CRC药物耐药性的新型治疗点.
- 探索核糖体生物发生在KRAS抑制剂耐受性中的作用.
主要方法:
- 在KRAS突变CRC细胞系中利用了KRAS信号抑制剂 (特拉美丁尼布,AMG510).
- 分析基因表达特征,以评估核糖体生物发生.
- 评估了RNA聚合酶I抑制与KRAS抑制剂结合的疗效.
- 在临床前模型中测试治疗效果,包括小鼠模型和患者衍生器官 (PDO).
主要成果:
- 抑制KRAS诱导了细胞状态,显著增强了核糖体生物发生.
- 这种KRAS抑制剂诱导的状态表现出对RNA聚合酶I抑制的脆弱性.
- 在临床前模型中,与特拉美丁尼和RNA聚合酶I抑制剂的联合治疗显示出协同作用的抗瘤效应.
- 高核糖体生物发生被确定为维持耐药状态的必要条件.
结论:
- 增强的核糖体生物发生是药物耐受性对CRC中KRAS抑制的关键机制.
- 向核糖体生物发生是一个有前途的治疗策略,用于KRAS突变的CRC.
- 针对KRAS信号和核糖体生物发生的组合疗法可以改善治疗结果.
更多相关视频
07:08Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
Published on: January 16, 2020
6.1K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
14.3K
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Ribosome Profiling
4.0K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
4.0K
The Nucleolus
10.2K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.2K
The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
